Evidence map›Paper›PMID 26791563›Full record

ArticleParasites & vectors2016

Oxadiazole-2-oxides may have other functional targets, in addition to SjTGR, through which they cause mortality in Schistosoma japonicum.

Li-Jun Song, Huan Luo, Wen-Hua Fan, Gu-Ping Wang, Xu-Ren Yin, Shuang Shen, Jie Wang, Yi Jin, Wei Zhang, Hong Gao and 4 more

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Li-Jun SongKey Laboratory on Technology for Disease Prevention and Control, Ministry of Health, Jiangsu Provincial Key laboratory of Parasite Molecular Biology, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, 214064, China. songlijun1025@163.com.
Huan LuoSchool of Pharmaceutical Science, Jiangnan University, Wuxi, 214122, China. 1464371728@qq.com.
Wen-Hua FanSchool of Pharmaceutical Science, Jiangnan University, Wuxi, 214122, China. fanwenhua1987@163.com.
Gu-Ping WangSchool of Pharmaceutical Science, Jiangnan University, Wuxi, 214122, China. p85615822@yeah.net.
Xu-Ren YinKey Laboratory on Technology for Disease Prevention and Control, Ministry of Health, Jiangsu Provincial Key laboratory of Parasite Molecular Biology, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, 214064, China. yinxuren@sohu.com.
Shuang ShenKey Laboratory on Technology for Disease Prevention and Control, Ministry of Health, Jiangsu Provincial Key laboratory of Parasite Molecular Biology, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, 214064, China. 2496049650@163.com.
Jie WangKey Laboratory on Technology for Disease Prevention and Control, Ministry of Health, Jiangsu Provincial Key laboratory of Parasite Molecular Biology, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, 214064, China. sunflower1230@163.com.
Yi JinKey Laboratory on Technology for Disease Prevention and Control, Ministry of Health, Jiangsu Provincial Key laboratory of Parasite Molecular Biology, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, 214064, China. 502240773@qq.com.
Wei ZhangKey Laboratory on Technology for Disease Prevention and Control, Ministry of Health, Jiangsu Provincial Key laboratory of Parasite Molecular Biology, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, 214064, China. 543608268@qq.com.
Hong GaoKey Laboratory on Technology for Disease Prevention and Control, Ministry of Health, Jiangsu Provincial Key laboratory of Parasite Molecular Biology, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, 214064, China. 648010057@qq.com.
Qian LiuKey Laboratory on Technology for Disease Prevention and Control, Ministry of Health, Jiangsu Provincial Key laboratory of Parasite Molecular Biology, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, 214064, China. 284661103@qq.com.
Wen-Long WangSchool of Pharmaceutical Science, Jiangnan University, Wuxi, 214122, China. wwenlong2011@163.com.
Bainian FengSchool of Pharmaceutical Science, Jiangnan University, Wuxi, 214122, China. fengbainian@jiangnan.edu.cn.
Chuan-Xin YuKey Laboratory on Technology for Disease Prevention and Control, Ministry of Health, Jiangsu Provincial Key laboratory of Parasite Molecular Biology, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, 214064, China. chxnyu@163.com.
Jiangnan University · CNJiangsu Institute of Parasitic Diseases · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSchistosomiasis is one of the world's major public health problems. Besides praziquantel (PZQ), there is currently no other effective treatment against schistosomiasis. The development of new antischistosomal agents to curb the emergence of PZQ resistance should be a high priority. Oxadiazole-2-oxides have been identified as potential antischistosomal reagents, with thioredoxin glutathione reductase (TGR) being one of their molecular targets.

methodsTo develop novel treatment reagents against Schistosoma japonicum, 30 novel oxadiazole-2-oxides were synthesised and their antischistosomal activities on juvenile and adult S. japonicum were evaluated in vitro and in vivo. Their inhibitory activities against S. japonicum thioredoxin glutathione reductase (SjTGR) were also analysed.

resultsMost of the oxadiazole-2-oxides showed good juvenile and adult S. japonica killing activities in vitro. However, the antischistosomal effects of these compounds were not positively correlated with either their inhibition of SjTGR, or with nitric oxide (NO) release. Compounds 4a, 4b, 7c, 13, 16 and 20 resulted in 87.7%, 83.1%, 87.1%, 84.6%, 90.8% and 69.5%, respectively, mortality in the adult worms, when used to treat infected mice at schistosomula stage. These mortality rates were similar to or higher than that of artemisinin. Furthermore, compounds 4a and 16 resulted in 66.7% and 69.4% reductions in the worm burdens, respectively, when infected mice were treated at the adult worm stage. These treatment effects were similar to PZQ. No differences in activity of the oxadiazole-2-oxides against female and male adult worms were observed. The toxicity of the oxadiazole-2-oxides on mammalian cells appeared to be similar to, or less than, that of PZQ.

conclusionsThe antischistosomal activity of the oxadiazole-2-oxides does not depend on NO production or the inhibition of SjTGR activity. There may be other functional targets of the oxadiazole-2-oxides in S. japonicum. Several of the novel oxadiazole-2-oxides synthesised in this study could be used to develop novel antischistosomal drugs and explore potential molecular targets.

Indexed as

AnimalsFemaleHeLa CellsHelminth ProteinsHumansMaleMiceMice, Inbred ICRMultienzyme ComplexesNADH, NADPH OxidoreductasesNitric OxideOxadiazolesOxidesPraziquantelSchistosoma japonicumSchistosomiasis japonicaHelminth ProteinsMultienzyme ComplexesNADH, NADPH OxidoreductasesNitric OxideOxadiazolesOxidesPraziquantelSchistosomicidesthioredoxin glutathione reductase

Identifiers

PMID26791563
PMCPMC4721062
OpenAlexW2286932609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.